TY  - GEN
AU  - Zhang,Qi
AU  - Wang,Xiao Long
AU  - Liao,Min Lei
AU  - Hu,Jian
AU  - Yang,Zhen Kun
AU  - Ding,Feng Hua
AU  - Zhang,Jian Sheng
AU  - Du,Run
AU  - Zhu,Tian Qi
AU  - Shen,Wei Feng
AU  - Zhang,Rui Yan
TI  - Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study
SN  - 1522-726X
PY  - 2016///0519
KW  - Aged
KW  - Biomarkers
KW  - blood
KW  - Chi-Square Distribution
KW  - China
KW  - Coronary Angiography
KW  - Coronary Artery Disease
KW  - Coronary Thrombosis
KW  - etiology
KW  - Creatine Kinase, MB Form
KW  - Drug-Eluting Stents
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Intention to Treat Analysis
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Myocardial Infarction
KW  - diagnosis
KW  - Odds Ratio
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Platelet Aggregation Inhibitors
KW  - administration & dosage
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Prospective Studies
KW  - Prosthesis Design
KW  - Risk Factors
KW  - Time Factors
KW  - Tirofiban
KW  - Treatment Outcome
KW  - Tyrosine
KW  - Up-Regulation
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1002/ccd.25864
ER  -